Literature DB >> 32049186

Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.

Luiz Alfredo Santiago1, Jussara Matyelle Rodrigues da Silva2, Orleâncio Gomes Ripardo de Azevedo3, Paulo Roberto Leitão de Vasconcelos4.   

Abstract

PURPOSE: To evaluate the effects of prednisolone against sodium diclofenac both with ciprofloxacin compared to artificial tears on the symptoms and signs of acute viral conjunctivitis.
METHODS: Study included 37 patients diagnosed with acute conjunctivitis and distributed by three groups: A (1% prednisolone acetate + ciprofloxacin (0.3%); B (Sodium diclofenac (0.1%) + ciprofloxacin (0.3%) and C (artificial tears + ciprofloxacin (0.3%). Patients received medication 6/6 hours daily. Signs and symptoms (e.g. lacrimation, burning, photophobia, etc.) were scored at baseline and on the first, third, fifth and seventh days and in the end of treatment using a standardized questionnaire and slit lamp anterior segment examination.
RESULTS: All three groups demonstrated an improvement in the signs and symptoms of conjunctivitis in their follow-up visits. There was no significant difference in symptom and sign scores between Group A and B and B and C in the study visits ( p >0.05). However, the comparison between groups A and C showed a clinical trend (p=0.05) on third evaluation suggesting better clinical action using the corticosteroids.
CONCLUSION: The prednisolone acetate was not superior to the use of sodium diclofenac or artificial tears in relieving the signs and symptoms of viral conjunctivitis.

Entities:  

Year:  2020        PMID: 32049186      PMCID: PMC7006370          DOI: 10.1590/s0102-865020190120000006

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  30 in total

1.  Conjunctivitis: diagnosis and management.

Authors:  M Wood
Journal:  Community Eye Health       Date:  1999

Review 2.  Adenovirus advances: new diagnostic and therapeutic options.

Authors:  Herbert E Kaufman
Journal:  Curr Opin Ophthalmol       Date:  2011-07       Impact factor: 3.761

Review 3.  Conjunctivitis: a systematic review of diagnosis and treatment.

Authors:  Amir A Azari; Neal P Barney
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

4.  Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1.

Authors:  E Uchio; S Takeuchi; N Itoh; N Matsuura; S Ohno; K Aoki
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

5.  Molecular epidemiology of adenoviral conjunctivitis in Hanoi, Vietnam.

Authors:  Xue-Hai Jin; Hiroaki Ishiko; Thanh Ha Nguyen; Takeshi Ohguchi; Masataka Akanuma; Koki Aoki; Shigeaki Ohno
Journal:  Am J Ophthalmol       Date:  2006-09-05       Impact factor: 5.258

6.  Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data.

Authors:  Brighu N Swamy; Michael Chilov; Kathy McClellan; Con Petsoglou
Journal:  Ophthalmic Epidemiol       Date:  2007 Sep-Oct       Impact factor: 1.648

7.  Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis.

Authors:  M J Azar; D K Dhaliwal; K S Bower; R P Kowalski; Y J Gordon
Journal:  Am J Ophthalmol       Date:  1996-06       Impact factor: 5.258

Review 8.  Adenoviral keratoconjunctivitis: an update.

Authors:  J J González-López; R Morcillo-Laiz; F J Muñoz-Negrete
Journal:  Arch Soc Esp Oftalmol       Date:  2012-09-25

9.  Prevalence of chlamydial eye infection in patients attending an eye clinic, a VD clinic, and in healthy persons.

Authors:  R Rönnerstam; K Persson; H Hansson; K Renmarker
Journal:  Br J Ophthalmol       Date:  1985-05       Impact factor: 4.638

Review 10.  Clinical features and treatment of adenovirus infections.

Authors:  Liesbeth Lenaerts; Erik De Clercq; Lieve Naesens
Journal:  Rev Med Virol       Date:  2008 Nov-Dec       Impact factor: 6.989

View more
  1 in total

Review 1.  Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.

Authors:  Su-Hsun Liu; Barbara S Hawkins; Sueko M Ng; Mark Ren; Louis Leslie; Genie Han; Irene C Kuo
Journal:  Cochrane Database Syst Rev       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.